EPO’s Central Staff Committee reports on arbitrary reallocation of patent applications from IPQC companies.

Here is the statement of companies involved:

• IPQC cannot comment on EPO internal proceedings.
• IPQC member companies explicitly reject and do not tolerate any form of special treatment of its European patent applications by the EPO.
• Rather, IPQC repeats its request for thorough and complete searches and examinations and points out that only valid and enforceable patents can contribute to innovation.
• IPQC member companies have requested from the EPO management an explanation of the allegations made by the Central Staff Committee of the EPO.